Device Respiratory

Remede System

Payments companies reported to CMS as associated with Remede System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$970Kassociated payments (2023-2025)
2,077clinicians with associated payments
1company reporting

By year

2023 $343K
2024 $326K
2025 $301K

Payments reported as associated with Remede System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Sleep Medicine (Internal Medicine) $209K
Advanced Heart Failure and Transplant Cardiology $157K
Pulmonary Disease $133K
Clinical Cardiac Electrophysiology $124K
Sleep Medicine (Family Medicine) $103K
Family $47K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Remede System

These are the largest totals companies reported as associated with Remede System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
William Abraham Columbus, OH Advanced Heart Failure and Transplant Cardiology $121,727.41
Shahrokh Javaheri Cincinnati, OH Sleep Medicine (Family Medicine) $64,718.55
Atul Malhotra San Diego, CA Sleep Medicine (Internal Medicine) $52,103.30
Qanta Ahmed Mineola, NY Sleep Medicine (Internal Medicine) $41,788.09
Lee Goldberg Philadelphia, PA Advanced Heart Failure and Transplant Cardiology $30,830.10
Alan Schwartz Baltimore, MD Pulmonary Disease $28,689.70
Paul Schurmann Houston, TX Clinical Cardiac Electrophysiology $24,512.23
Nancy Collop Atlanta, GA Sleep Medicine (Internal Medicine) $23,482.11
Neomi Shah Bronx, NY Pulmonary Disease $18,636.22
Samer Al-Khudari Chicago, IL Otolaryngology $17,519.82

Prescribed Remede System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.